The challenge of administering anti-tuberculosis treatment in infants and pre-school children. pTBred Magistral Project

Grupo de trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica, 2003, Interpretación de la prueba de tuberculina en niños, An Pediatr (Barc), 59, 582, 10.1157/13054341 Grupo de trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica, 2006, Documento de consenso sobre el tratamiento de la exposición a tuberculosis y de la infección tuberculosa latente en niños, An Pediatr (Barc), 64, 59, 10.1016/S1695-4033(06)70010-8 Grupo de trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica, 2008, Documento de consenso sobre el tratamiento de la tuberculosis extrapulmonar y formas complicadas de tuberculosis pulmonar, An Pediatr (Barc), 69, 271, 10.1157/13125824 Mellado Peña, 2009, Documento de consenso de la SEIP sobre la tuberculosis resistente a fármacos, An Pediatr (Barc), 71, 447, 10.1016/j.anpedi.2009.07.036 Grupo de trabajo de Tuberculosis de la Sociedad Española de Infectología Pediátrica, 2007, Documento de consenso sobre el tratamiento de la tuberculosis pulmonar en niños, An Pediatr (Barc), 66, 597, 10.1157/13107395 Moreno-Pérez, 2010, Diagnóstico de la tuberculosis en la edad pediátrica, An Pediatr (Barc), 72, 10.1016/j.anpedi.2010.01.002 Comité de Medicamentos de la Asociación Española de Pediatría, 2012 Grupo de Farmacotecnia (editores). Periodo de validez y caducidad de formas farmacéuticas no estériles orales líquidas [monografía en Internet]. Sociedad Española de Farmacia Hospitalaria: Madrid, 2015. [accessed 01/07/15]. Available from: http://gruposdetrabajo.sefh.es/farmacotecnia/images/stories/Boletines/BOLETIN1_2015.pdf 2014 Thee, 2011, Pharmacokinetics of isoniazid, rifampin, and pyrazinamide in children younger than two years of age with tuberculosis: evidence for implementation of revised World Health Organization recommendations, Antimicrob Agents Chemother, 55, 5560, 10.1128/AAC.05429-11 World Health Organization, 2009 Red Española de Estudio de la Tuberculosis Pediátrica (pTBred) [accessed 01.07.15]. Available from: https://twitter.com/ptbred_spain Mellado Peña, 2012 World Health Organization. Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. WHO/HTM/TB/2014.03 [accessed 01.07.15]. Available from: http://apps.who.int/medicinedocs/documents/s21535en/s21535en.pdf Verhagen, 2012, Pharmacokinetics of anti-tuberculosis drugs in Venezuelan children younger than 16 years of age: supportive evidence for the implementation of revised WHO dosing recommendations, Trop Med Int Health, 17, 1449, 10.1111/tmi.12003 Web del Grupo Español de Farmacia Pediátrica [accessed 01.07.15]. Available from: http://www.sefh.es/gefp_formulas.php?seccion=A Ehring, 1971, Dissolved tuberculostatics. A safe intake method during hospitalization, Prax Pneumol, 25, 395 Piñeiro Pérez, 2014, Conocimiento sobre el uso de fármacos off-label en pediatría. Resultados de una encuesta pediátrica nacional 2012–2013 (estudio OL-PED), An Pediatr (Barc), 81, 16, 10.1016/j.anpedi.2013.10.004 Albanna, 2013, Fixed-dose combination antituberculosis therapy: a systematic review and meta-analysis, Eur Respir J, 42, 721, 10.1183/09031936.00180612 Agrawal, 2004, Comparative bioavailability of rifampicin, isoniazid and pyrazinamide from a four drug fixed dose combination with separate formulations at the same dose levels, Int J Pharm, 276, 41, 10.1016/j.ijpharm.2004.02.019 Lienhardt, 2011, Efficacy and safety of a 4-drug fixed-dose combination regimen compared with separate drugs for treatment of pulmonary tuberculosis: The Study C randomized controlled trial, JAMA, 305, 1415, 10.1001/jama.2011.436 American Academy of Pediatrics; 2011, editores. Nutrition: what every parent needs to know [monografía en Internet] [última actualización 5 Jun 2015; accessed 01.07.15]. Elk Grove Village: American Academy of Pediatrics. Available from: https://www.healthychildren.org/Spanish/healthy-living/nutrition/Paginas/Food-and-Medication-Interactions.aspx Levy, 2015, Ethambutol-related impaired visual function in childrens less than five years of age treated for a mycobacterial infection: diagnosis and evolution, Pediatr Infect Dis J, 10.1097/INF.0000000000000589 Donald, 2006, Ethambutol dosage for the treatment of children: literature review and recommendations, Int J Tuberc Lung Dis, 10, 1318